- Home
- TELA
TELA
TELA Bio Inc.
as 07-26-2024 4:00pm EST
TELA Bio Inc is a United States-based medical technology company. The company is involved in developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. Its reinforced tissue matrices called OviTex improve the clinical outcomes and reduce costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. The company's second portfolio of products, the OviTex PRS Reinforced Tissue Matrix, addresses unmet needs in plastic and reconstructive surgery.
| Founded: | 2012 | Country: | United States |
| Employees: | N/A | City: | MALVERN |
| Market Cap: | 114.2M | IPO Year: | 2019 |
| Target Price: | $13.25 | AVG Volume (30 days): | 416.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.67 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.03 - $10.22 | Next Earning Date: | 08-12-2024 |
| Revenue: | $63,147,000 | Revenue Growth: | 40.03% |
| Revenue Growth (this year): | 31.58% | Revenue Growth (next year): | 26.86% |
Stock Insider Trading Activity of TELA Bio Inc. (TELA)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | TELA | 10% Owner | Jun 28 '24 | Sell | $4.74 | 378,000 | $1,791,720.00 | 2,457,542 | SEC Form 4 |
| ORBIMED ADVISORS LLC | TELA | 10% Owner | Jun 28 '24 | Sell | $4.68 | 13,700 | $64,116.00 | 2,443,842 | SEC Form 4 |
| ORBIMED ADVISORS LLC | TELA | 10% Owner | Jun 28 '24 | Sell | $4.54 | 36,600 | $166,164.00 | 2,407,242 | SEC Form 4 |
| Firestone Gregory A. | TELA | Chief Business Officer | Dec 5 '23 | Buy | $5.65 | 2,600 | $14,688.44 | 35,511 | SEC Form 4 |
| KOBLISH ANTONY | TELA | Chief Executive Officer | Nov 14 '23 | Buy | $4.54 | 11,000 | $49,976.30 | 303,634 | SEC Form 4 |
| Cuca Roberto | TELA | COO and CFO | Nov 14 '23 | Buy | $4.49 | 10,000 | $44,938.00 | 62,371 | SEC Form 4 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | TELA | 10% Owner | Apr 1 '20 | Buy | $7.47 | 15,000 | $112,050.00 | 1,169,231 | SEC Form 4 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | TELA | 10% Owner | Apr 1 '20 | Buy | $8.01 | 15,000 | $120,150.00 | 1,184,231 | SEC Form 4 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | TELA | 10% Owner | Apr 1 '20 | Buy | $8.01 | 9,634 | $77,168.34 | 1,193,865 | SEC Form 4 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | TELA | 10% Owner | Apr 1 '20 | Buy | $8.10 | 17,866 | $144,714.60 | 1,211,731 | SEC Form 4 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | TELA | 10% Owner | Apr 1 '20 | Buy | $8.20 | 20,000 | $164,000.00 | 1,231,731 | SEC Form 4 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | TELA | 10% Owner | Apr 1 '20 | Buy | $8.37 | 15,000 | $125,550.00 | 1,246,731 | SEC Form 4 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | TELA | 10% Owner | Apr 1 '20 | Buy | $8.47 | 25,000 | $211,750.00 | 1,271,731 | SEC Form 4 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | TELA | 10% Owner | Apr 1 '20 | Buy | $7.96 | 10,000 | $79,600.00 | 1,281,731 | SEC Form 4 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | TELA | 10% Owner | Apr 1 '20 | Buy | $8.07 | 15,000 | $121,050.00 | 1,296,731 | SEC Form 4 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | TELA | 10% Owner | Apr 1 '20 | Buy | $7.99 | 12,500 | $99,875.00 | 1,309,231 | SEC Form 4 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | TELA | 10% Owner | Apr 1 '20 | Buy | $8.00 | 17,500 | $140,000.00 | 1,326,731 | SEC Form 4 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | TELA | 10% Owner | Apr 1 '20 | Buy | $8.25 | 25,000 | $206,250.00 | 1,351,731 | SEC Form 4 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | TELA | 10% Owner | Apr 1 '20 | Buy | $8.06 | 7,000 | $56,420.00 | 1,358,731 | SEC Form 4 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | TELA | 10% Owner | Apr 1 '20 | Buy | $8.32 | 3,037 | $25,267.84 | 1,361,768 | SEC Form 4 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | TELA | 10% Owner | Apr 1 '20 | Buy | $9.14 | 10,000 | $91,400.00 | 1,371,768 | SEC Form 4 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | TELA | 10% Owner | Apr 1 '20 | Buy | $9.98 | 15,000 | $149,700.00 | 1,386,768 | SEC Form 4 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | TELA | 10% Owner | Apr 1 '20 | Buy | $9.48 | 5,000 | $47,400.00 | 1,391,768 | SEC Form 4 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | TELA | 10% Owner | Apr 1 '20 | Buy | $12.48 | 10,000 | $124,800.00 | 1,401,768 | SEC Form 4 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | TELA | 10% Owner | Apr 1 '20 | Buy | $12.39 | 12,600 | $156,114.00 | 1,414,368 | SEC Form 4 |
Latest TELA Bio Inc. News
TELA Breaking Stock News: Dive into TELA Ticker-Specific Updates for Smart Investing
GlobeNewswire
a day ago
TELA Bio to Participate in the Canaccord Genuity 44th Annual Growth Conference
GlobeNewswire
4 days ago
TELA Bio to Announce Second Quarter 2024 Financial Results
Reuters
2 months ago
Spirit Airlines not considering Chapter 11 bankruptcy, CNBC reports
ACCESSWIRE
2 months ago
AllianceBernstein: Office Space: Looking Past the Doom and Gloom
GlobeNewswire
2 months ago
Aqua-Tots Swim School Splashes Into Summer With Highly-Anticipated Grand Opening in Henderson, Nevada
Newsfile
2 months ago
DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio
GlobeNewswire
2 months ago
Decisions of the Ordinary General Shareholders' Meeting of Novaturas AB
ACCESSWIRE
2 months ago
Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine
Compare TELA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TELA TELA Bio Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.